Claims
- 1. A compound of the formula ##STR10## wherein W is vinylene, methyl-vinylene, or ethylene;
- m is 0, 1, or 2;
- D is straight or branched alkylene of 2 to 6 carbon atoms, straight or branched hydroxy-alkylene of 3 to 6 carbon atoms, or xylylene;
- R.sub.1 is hydrogen or alkyl of 1 to 3 carbon atoms;
- R.sub.2 is cycloalkyl of 3 to 6 carbon atoms; aryl of 6 or 10 carbon atoms, alkylaryl of 7 to 10 carbon atoms, or aralkyl of 7 to 11 carbon atoms, where the aryl nucleus may be unsubstituted or mono-substituted by alkyl of 1 to 4 carbon atoms, hydroxyl, methoxy, amino, acetylamino, nitro, carboxyl, cyclohexyl, phenyl, or halogen, and a mono-substituted phenyl moiety may, in addition, be mono- or di-substituted by alkyl of 1 to 4 carbon atoms, halogen, or both, where said substituents on the phenyl moiety may be identical or different from each other; triphenylmethyl; N-methyl-cyclohexylamino-carbonylmethyl; amino-iminomethyl; pyridyl; pyridylmethyl; furfuryl; benzimidazolyl; benzthiazolyl; pyrimidyl; 1,2,4-triazolyl; quinolyl; quinazoline-4-one-yl; 4,5-bis-(p-chlorphenyl)-oxazole-2-yl; pyridyl-oxide; methylpyridyl; methoxypyridyl; fluoropyridyl; chloropyridyl; aminopyridyl; acetylaminopyridyl; or, when m is 1 or D is hydroxyalkylene or xylylene, also alkyl of 1 to 6 carbon atoms; and
- R.sub.3 and R.sub.4 are each hydrogen, halogen, alkyl of 1 to 4 carbom atoms, amino, acetylamino or nitro.
- 2. A compound of claim 1,
- wherein
- W is vinylene, methyl-vinylene, or ethylene;
- m is 0, 1 or 2;
- D is straight or branched alkylene of 2 to 6 carbon atoms, straight or branched hydroxy-alkylene of 3 to 6 carbon atoms, or xylylene;
- R.sub.1 is hydrogen or alkyl of 1 to 3 carbon atoms;
- R.sub.2 is cyclohexyl, benzyl, naphthyl, pyridyl, pyrimidyl, 1,2,4-triazolyl, pyridyl-oxide, furfuryl, triphenylmethyl, quinolyl, benzimidazolyl, benzthiazolyl, quinazoline-4-one-yl, 4,5-bis(p-chlorophenyl)-oxazol-2-yl, N-methyl-cyclohexylamino-carbonyl-methyl, amino-iminomethyl, phenyl unsubstituted or substituted by carboxyl, hydroxyl, methoxy, amino, acetylamino, nitro, cyclohexyl or phenyl; phenyl mono- or disubstituted by halogen and/or alkyl of 1 to 4 carbon atoms; or hydroxyphenyl, halophenyl or aminophenyl, each substituted by two halogen atoms or by two alkyl groups of 1 to 4 carbon atoms;
- R.sub.3 is hydrogen, chlorine, bromine, methyl, amino, acetylamino or nitro; and
- R.sub.4 is hydrogen.
- 3. A compound of claim 1
- wherein
- W is vinylene, methyl-vinylene or ethylene;
- m is 0, 1 or 2;
- D is alkylene of 2 to 5 carbon atoms or hydroxyalkylene of 3 to 5 carbon atoms;
- R.sub.1 is hydrogen;
- R.sub.2 is cyclohexyl, phenyl, benzyl, naphthyl, biphenylyl, cyclohexylphenyl, pyridyl, methylphenyl, methoxyphenyl, fluorophenyl, chlorophenyl, dichlorophenyl, trichlorophenyl, bromophenyl, dibromophenyl, bromomethylphenyl, amino-dibromophenyl or hydroxy-ditert.butylphenyl; and
- R.sub.3 and R.sub.4 are each hydrogen.
- 4. A compound of claim 1
- wherein
- W is ethylene, vinylene or 2-methylvinylene;
- m is 0, 1 or 2;
- R.sub.2 is cyclohexyl, phenyl, benzyl, naphthyl-(2), 2-methoxyphenyl, 4-chlorophenyl, 3,4-dichlorophenyl, 2,5-dichlorophenyl, 4-hydroxy-3,5-di-tert.butylphenyl, 4-amino-3,5-dibromophenyl or pyridyl-(2);
- D is ethylene, n-propylene, n-butylene or 2-hydroxy-n-propylene; and
- R.sub.1, R.sub.3 and R.sub.4 are each hydrogen.
- 5. The compound of claim 4, which is 6-(4-phenylsulfinyl-butoxy)-3,4-dihydro-carbostyril.
- 6. The compound of claim 4, which is 6-[4-(3,4-dichlorophenyl-sulfinyl)-butoxy]-3,4-dihydro-carbostyril.
- 7. The compound of claim 4, which is 6-[4-(2-pyridyl-sulfonyl)-butoxy]-carbostyril.
- 8. A cardiotonic or antithrombotic pharmaceutical dosage unit composition consisting essentially of an inert pharmaceutical carrier and an effective cardiotonic or antithrombotic amount of a compound of claim 1.
- 9. The method of increasing the strength of the heart muscle contraction or preventing or relieving thrombosis in a warm-blooded animal in need of such treatment, which comprises perorally, parenterally or rectally administering to said animal an effective cardiotonic or antithrombotic amount of a compound of claim 1.
Priority Claims (3)
Number |
Date |
Country |
Kind |
2931741 |
Aug 1979 |
DEX |
|
2806721 |
Feb 1978 |
DEX |
|
2853314 |
Dec 1978 |
DEX |
|
CROSS-REFERENCE TO RELATED APPLICATION
This application is a continuation-in-part of copending U.S. patent application Ser. No. 10,221 filed Feb. 8, 1979, now abandoned.
Foreign Referenced Citations (2)
Number |
Date |
Country |
2806721 |
Aug 1979 |
DEX |
54-101387 |
Sep 1974 |
JPX |
Non-Patent Literature Citations (1)
Entry |
Nakagawa, et al., Chemical Abstracts, vol. 85, 94239q. (1976). |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
10221 |
Feb 1979 |
|